High-Risk Cutaneous Squamous Cell Carcinoma

High-Risk Cutaneous Squamous Cell Carcinoma Purpose of Review The aim of this report is to review the literature on patients diagnosed with a “high-risk” cutaneous squamous cell carcinoma (cSCC), defined as the subset (5–10%) of cSCC patients at increased risk of developing predominantly local and/ or regional recurrence and, to a lesser extent, distant metastasis. Recent Findings There are no universally accepted criteria for defining or managing patients with a high-risk cSCC. We reviewed the literature and examined risk stratification, management strategies, and promising future directions. A new staging system, from the Brigham and Women’s Hospital, has provided important data on high-risk cSCC patients, highlighting the increasing risks associated with the interaction of a number of high-risk independent variables a patient has. Summary Only a minority of cSCC patients can be considered as high risk for developing recurrence and potentially dying from cSCC. Most patients are cured following local treatment, usually surgery. It is the high-risk patients that need to be identified and managed appropriately, often requiring multimodality treatment. . . . Keywords High risk Nodal metastases Radiotherapy Squamous cell carcinoma Introduction therefore examine risk stratification, management strategies, and promising future directions. Cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Otorhinolaryngology Reports Springer Journals

High-Risk Cutaneous Squamous Cell Carcinoma

Loading next page...
 
/lp/springer_journal/high-risk-cutaneous-squamous-cell-carcinoma-1GyVgPpN8l
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Otorhinolaryngology
eISSN
2167-583X
D.O.I.
10.1007/s40136-018-0194-4
Publisher site
See Article on Publisher Site

Abstract

Purpose of Review The aim of this report is to review the literature on patients diagnosed with a “high-risk” cutaneous squamous cell carcinoma (cSCC), defined as the subset (5–10%) of cSCC patients at increased risk of developing predominantly local and/ or regional recurrence and, to a lesser extent, distant metastasis. Recent Findings There are no universally accepted criteria for defining or managing patients with a high-risk cSCC. We reviewed the literature and examined risk stratification, management strategies, and promising future directions. A new staging system, from the Brigham and Women’s Hospital, has provided important data on high-risk cSCC patients, highlighting the increasing risks associated with the interaction of a number of high-risk independent variables a patient has. Summary Only a minority of cSCC patients can be considered as high risk for developing recurrence and potentially dying from cSCC. Most patients are cured following local treatment, usually surgery. It is the high-risk patients that need to be identified and managed appropriately, often requiring multimodality treatment. . . . Keywords High risk Nodal metastases Radiotherapy Squamous cell carcinoma Introduction therefore examine risk stratification, management strategies, and promising future directions. Cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers

Journal

Current Otorhinolaryngology ReportsSpringer Journals

Published: Apr 14, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off